Cas:1131622-39-3 4-[(3-ethylpiperazin-1-yl)methyl]benzoic acid manufacturer & supplier

Chemical Name:4-[(3-ethylpiperazin-1-yl)methyl]benzoic acid

CAS.NO:1131622-39-3

Synonyms:4-[(3-ethylpiperazin-1-yl)methyl]benzoic acid

Molecular Formula:C₁₄H₂₀N₂O₂

Molecular Weight:248.32100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:52.57000

Exact Mass:248.15200

LogP:1.83530

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-[(3-ethylpiperazin-1-yl)methyl]benzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[(3-ethylpiperazin-1-yl)methyl]benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[(3-ethylpiperazin-1-yl)methyl]benzoic acid Use and application,4-[(3-ethylpiperazin-1-yl)methyl]benzoic acid technical grade,usp/ep/jp grade.

Related News: The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction. (-)-3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione manufacturers “It’s the achievement of a dream for an Italian company, I had chills,” he told Forbes in a Zoom interview on Thursday. “For the first three or four decades, my grandfather was in start-up mode [without] making money.” 1-Phenyl-1,8-diazaspiro[4.5]decan-2-one hydrochloride (1:1) suppliers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. 3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)benzoic acid vendor & factory The European Commission (EC) has approved MSD and Bayer’s Verquvo for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction.,“It’s the achievement of a dream for an Italian company, I had chills,” he told Forbes in a Zoom interview on Thursday. “For the first three or four decades, my grandfather was in start-up mode [without] making money.”